Ali R Yazdanyar, DO, PhD, MMM

Ali R Yazdanyar, DO, PhD, MMM, MS

Dr Yazdanyar is an Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania and an attending physician within the Division of Hospital Medicine. He earned his Doctor of Philosophy in Epidemiology from the University of Pittsburgh, a Master's (MS) in Applied Statistics from the University of Delaware, and a master's in medical management (MMM) from Carnegie Mellon University. He was a Post-Doctoral fellow in Epidemiology at the Graduate School of Public Health at the University of Pittsburgh. His current research focuses on clinical outcomes among hospitalized adults, perioperative medicine among patients with rheumatologic disorders, and frailty.

Wednesday, June 26, 2024
9:00 am
Rebecka S. Hess, DVM, MSCE, Dipl. ACVIM

Rebecka S. Hess, DVM, MSCE, Dipl. ACVIM

Dr. Rebecka Hess received her Doctor of Veterinary Medicine degree in 1992 from the Hebrew University of Jerusalem in Israel. She completed an internship in small animal medicine in 1994 and a residency in small animal internal medicine in 1996, both at the University of Pennsylvania, School of Veterinary Medicine, where she is currently Professor and Chief of Internal Medicine. Dr. Hess completed the Master of Science in Clinical Epidemiology (MSCE) program at the Perelman School of Medicine of the University of Pennsylvania in 2017. She has received numerous research and teaching awards including the Christian R. and Mary F. Lindback Award for Distinguished Teaching. Her research and publications focus on diabetes and other endocrinopathies in dogs and cats, topics of which she is invited to speak on nationally and internationally.  She is a Diplomate of the American College of Veterinary Internal Medicine.

Learn more about Dr. Hess's work: https://www.vet.upenn.edu/people/faculty-clinician-search/REBECKAHESS

Wednesday, June 12, 2024
9:00 am
Elizabeth Foglia, MD MSCE

Elizabeth Foglia, MD MSCE

Dr. Foglia is an Associate Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine and an academic neonatologist at the Children’s Hospital of Philadelphia and the Hospital of the University of Pennsylvania. She completed her medical school training at Washington University School of Medicine, and she performed her pediatric residency training at the Children’s Hospital of Philadelphia. She was a neonatology fellow at the Children’s Hospital of Philadelphia, during which time she pursued advanced training through the Master of Science in Clinical Epidemiology program at the University of Pennsylvania.

The over-arching goal of her research program is to generate high quality evidence to prevent mortality and morbidity for high-risk infants who require resuscitation and respiratory management.  Output from her group has had immediate impact on national and international neonatal resuscitation guidelines.  She leads the following multi-center neonatal clinical trials: Diaphragmatic Initiated Ventilatory Assist (DIVA) funded by NHLBI; Optimizing Tracheal Intubation Outcomes and Neonatal Safety (OPTION SAFE) funded by NICHD; and Supraglottic Airway for Resuscitation (SUGAR), funded by PCORI.  
 
Dr. Foglia serves on the Executive Committee for the international NEAR4NEOS network, and she is the Scientific PI for the American Academy of Pediatrics Delivery Room Intervention and Evaluation (DRIVE) Network, a novel research consortium of delivery hospitals.  She has served on the AAP Neonatal Resuscitation Program Steering Committee, and the Neonatal Life Support Taskforce for the International Liaison Committee on Resuscitation, which generates treatment guidelines for neonatal resuscitation used globally.

 

Mohsin Shah MBBS, MSCE

Mohsin Shah, MBBS, MSCE

Mohsin Shah is the Director of Global Medical Evidence Generation - Hematology-Oncology at Bristol Myers Squibb, where he leads the strategic development and execution of the evidence generation plan for the hematology portfolio, with a primary focus on myeloid cancers, including Clinical Research Collaborations (CRCs), Medical Affairs Sponsored Trials (MAST), and Investigator-Sponsored Research Studies (ISRs). Partnering closely with Medical Strategy, RWE/Epidemiology, Clinical Operations, Regulatory, HEOR, and Access & Value, as well as external investigators, Dr. Shah works to uncover new clinical development opportunities and address unmet needs within the current development plan.

As a clinical pharmacoepidemiologist by training with over eight years of experience conceptualizing, designing, and leading real-world studies, Dr. Shah has published over 26 peer-reviewed articles and presented over 20 conference presentations. He completed a T-32-funded postdoctoral fellowship in applied pharmacoepidemiology and graduated with a Master of Science in Clinical Epidemiology (MSCE) degree from the Perelman School of Medicine, University of Pennsylvania. Before this training, he completed a postdoctoral fellowship in internal medicine and oncologic emergency medicine at the UT MD Anderson Cancer Center. He received his medical doctorate from the University of Health Sciences. Dr. Shah’s expertise lies in (a) evaluating novel interventions using real-world data and state-of-the-art biostatistical and missing data methods (b) generating real-world evidence from such novel interventions, and (c) optimizing pharmacoepidemiology research methods to adapt to patients with cancer.

Alternate email: mohsin.shah@boehringer-ingelheim.com

 

Dovie L. Watson, MD, MSCE

Dovie L. Watson, MD, MSCE

Dr. Watson is an infectious diseases physician-scientist whose clinical HIV research program focuses on accelerating equitable HIV pre-exposure prophylaxis (PrEP) service delivery and eliminating stigma and discrimination in sexual health, with particular attention to Black LGBTQ+ adults in the United States. She has particular expertise in clinical ID epidemiology, health equity, HIV prevention research, LGBTQ+ Health, and community-engaged research. Dr. Watson’s work has led to several publications delineating provider-level, structural, and systemic barriers and facilitators to equitable PrEP equity for patients with multiple marginalized identities. She is the recipient of institutional and federal grants from the National Institutes of Health, including a Career Development Award (K23) from the National Institute of Mental Health, which an equity-focused implementation science grant to design and pilot a novel multifaceted implementation strategy to address provider behaviors and organization-level practices that affect PrEP equity for Black patients in Philadelphia. Dr. Watson’s long-term goal is to eliminate behavioral and structural barriers to PrEP implementation within clinical and community settings in order to achieve PrEP equity among Black and LGBTQ+ populations.

Dr. Watson received her B.A. degree from Cornell University and her medical degree from the Northwestern University. She completed her internship and residency at the University of Chicago, during which time she also completed a Medical Ethics fellowship at the University of Chicago MacLean Center for Clinical Medical Ethics. She subsequently completed her Infectious Diseases (ID) fellowship and obtained her Master of Science in Clinical Epidemiology (MSCE) degree from the University of Pennsylvania.

Wednesday, May 29, 2024
9:00 am

Angela DeMichele, MD, MSCE, FASCO

Subscribe to